乙胺在心力衰竭患者中的有效性:系统性审查和元分析
Sanjay Eda1, Mandeep Kaur2, Mian M Rehman3
1Medicine, MNR Medical College and Hospital, Sangareddy, IND.
Cureus
|January 16, 2025
概括
乙胺增强了急性心力衰竭患者的液体排出. 这种辅助性利尿疗法增强了自然尿和利尿,但没有显著影响死亡率,因此需要进一步研究.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 急性心力衰竭 (AHF) 带来了重大管理挑战,特别是在流体过载方面.
- 尿剂耐药性是AHF的常见并发症,需要新的治疗策略.
- 循环利尿剂是标准治疗方法,但它们的疗效可能有限.
研究的目的:
- 系统地审查和元分析乙醇胺作为AHF的辅助利尿剂的疗效和安全性.
- 评估阿西塔佐胺对AHF患者的自然尿,尿和死亡率的影响.
主要方法:
- 在PubMed,Embase,Cochrane图书馆和Scopus进行了全面的文献搜索.
- 七项研究 (五项RCT,两项观察性研究) 被纳入了元分析.
- 疗效结局包括自然尿和尿液;安全结局是全因死亡率.
主要成果:
- 与对照人群相比,乙醇胺显著增加了平均尿量 (MD 52.72 mmol) 和平均尿量 (MD 432.88 mmol).
- 没有观察到任何原因死亡率的显著差异 (RR:1.23,p=0.25).
- 对于自然尿液 (I2=90%),但对于利尿液 (I2=0%) 则没有发现高异质性.
结论:
- 当添加到AHF中标准循环利尿剂时,乙胺有效地增强了液体的排出.
- 它显示出作为辅助疗法的承诺,用于管理AHF的液体过载.
- 需要进一步的大规模试验来确认长期结果并确定最佳的患者亚组.
相关概念视频
01:26Heart Failure Drugs: Inotropic Agents
2.0K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
2.0K
01:22Heart Failure Drugs: Diuretics
1.6K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.6K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.9K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.9K
01:22Heart Failure Drugs: β-Blockers
2.7K
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
2.7K
01:29Heart Failure II: Pathophysiology
1.9K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.9K
01:30Heart Failure V: Medical Management
626
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
626